Special Offering :
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
The Europe Contrast Injector Systems Market would witness market growth of 7.5 % CAGR during the forecast period (2018 – 2024). Contrast injector systems are medical devices which use contrast media to improve the visibility of complex body structures, namely body fluids, tissues, arteries, and veins. The diagnostic process is conducted using various imaging procedures such as computed tomography (CT), magnetic resonance imaging (MRI), and angiography. Advanced healthcare spaces are swiftly adopting contrast injector techniques mainly because injector systems offer comprehensive imagery by way of computed tomography (CT), magnetic resonance imaging (MRI), angiography, and others. Technological innovations help with the development of inexpensive and entirely automated contrast injector approaches. There are considerable technological advancements in contrast injector systems, which have resulted in availability of advanced treatment options for the management of chronic ailments. The demand for contrast injector devices is on a continuous growth due to rise in geriatric populace, susceptible to chronic illnesses and due to increased volume of diagnostic treatments globally.
Based on Application, the market is segmented into Geospatial Mapping, Disaster Management, Energy & Resource Management, Surveillance & Monitoring, and Others. Based on End User, the market is segmented into Government, Energy, Defense, Agriculture & Forestry, Media & Entertainment, Civil Engineering & Archaeology, and Others. . Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bayer AG, Angiodynamics Inc., GE Healthcare (A Healthcare Division of GE Company), Medtron AG, Nemoto Kyorindo Co., Ltd., Sino Medical- Device Technology Co., Ltd., Shenzhen Seacrown Electromechanical Co., Ltd., Ulrich GmbH & Co. Kg, Vivid Imaging and Guerbet Group.
Scope of the Study
- Interventional Radiology
- Interventional Cardiology
- CT Injector Systems
- MRI Injector Systems
- Angiography Injector Systems
- Injector Head
By End User
- Rest of Europe
- Bayer AG
- Angiodynamics Inc.
- GE Healthcare (A Healthcare Division of GE Company)
- Medtron AG
- Nemoto Kyorindo Co., Ltd.
- Sino Medical- Device Technology Co., Ltd.
- Shenzhen Seacrown Electromechanical Co., Ltd.
- Ulrich GmbH & Co. Kg
- Vivid Imaging
- Guerbet Group
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free